Ajei Gopal
About Ajei Gopal
Appointed to the Synopsys board on July 17, 2025 in connection with the completion of the Ansys acquisition; he joined as a non-employee director subject to Synopsys’ standard director program (cash retainer and RSUs) and standard indemnification agreement . He served as President & CEO of Ansys (2017–2025), previously as President & COO (2016), was an operating partner at Silver Lake (2013–2016, including a secondment as Symantec interim President & COO in 2016), and earlier a Senior Vice President at Hewlett Packard Enterprise (2011–2013) . External governance roles include director of Fiserv, Inc. (since 2024) and trustee of Carnegie Mellon University (since 2022); prior public board service includes Citrix (2017–2021) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Ansys, Inc. | President & CEO; previously President & COO | CEO 2017–2025; P/COO 2016 | Led the company through sale to Synopsys; brings systems simulation leadership for post-merger integration |
| Silver Lake | Operating Partner | 2013–2016 | PE operating leadership; seconded to Symantec as interim P/COO in 2016 |
| Symantec (now Gen Digital) | Interim President & COO (secondment from Silver Lake) | 2016 | Executive transition/operations leadership |
| Hewlett Packard Enterprise | Senior Vice President | 2011–2013 | Enterprise tech operating experience |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Fiserv, Inc. | Director | 2024–present | Current public company directorship |
| Carnegie Mellon University | Trustee | 2022–present | Higher-education board role |
| Citrix Systems | Director | 2017–2021 | Prior public company board experience |
Board Governance
- Synopsys appointment: Board size increased from nine to eleven at closing of the Ansys deal; Gopal and Ravi Vijayaraghavan were appointed pursuant to the merger agreement effective July 17, 2025 .
- Committees: At appointment, Gopal was not assigned to any Synopsys board committees . The proxy details committee composition as of the April 10, 2025 annual meeting (pre-acquisition) and post-meeting roles, but does not yet include Gopal on any committee .
- Independence and conflicts: Non-employee director; no family relationships with Synopsys directors/executives and no material related-party transactions requiring disclosure under Item 404(a) at appointment .
- Indemnification: Entered Synopsys’ standard director indemnification agreement (form filed previously) .
- Board attendance context: Synopsys’ board held six meetings in fiscal 2024 and each then-serving director attended >75% of board/committee meetings; this predates Gopal’s appointment .
- Stockholder oversight context: 2025 annual meeting results included approval of say‑on‑pay and equity plan amendments; board leadership updates included a new Lead Independent Director post‑meeting .
Fixed Compensation (Synopsys Non‑Employee Director Program)
| Element | Amount/Terms | Source |
|---|---|---|
| Annual cash retainer (Board) | $125,000, paid in advance quarterly; prorated in first year | |
| Lead Independent Director fee | +$30,000 per year (context, not specific to Gopal) | |
| Committee Chair fees | Audit Chair +$40,000; Comp Chair +$25,000; Gov Chair +$25,000 | |
| Committee member fees | Audit member +$15,000; Comp member +$10,000; Gov member +$10,000 | |
| Travel reimbursement | Reimbursed per Corporate Travel Policy |
Notes: No per‑meeting fees. As of FY2025, Synopsys made no changes to non‑employee director compensation levels vs. FY2024 .
Performance Compensation (Equity; time‑based for Directors)
| Award Type | Value/Grant Practice | Vesting | Source |
|---|---|---|---|
| Initial RSU (on appointment) | $350,000 grant date fair value | Vests in equal installments immediately before each of the first three annual meetings following grant, subject to continued board service | |
| Interim RSU (if appointed between annual meetings) | Pro‑rated portion of $200,000 | Vests immediately before the first annual meeting following grant | |
| Annual RSU (recurring policy context) | ~$200,000 full‑value restricted stock (FY2024 example) | Vests immediately before next annual meeting; in FY2024, directors received 356 shares each at $561.23 grant price |
Policy highlights for director equity: full‑value, time‑based; no performance‑based equity for directors; robust stock ownership guidelines; hedging and pledging prohibited .
Other Directorships & Interlocks
| Company | Type | Role | Potential Interlock/Conflict Consideration |
|---|---|---|---|
| Fiserv, Inc. | Public | Director (since 2024) | No Synopsys‑specific related‑party transactions disclosed; monitor for any commercial relationships (none disclosed at appointment) |
| Carnegie Mellon University | Non‑profit | Trustee (since 2022) | None disclosed |
| Citrix Systems | Public (prior) | Director (2017–2021) | Historical; no current interlock |
Overboarding policy context: Synopsys limits executives of public companies to serve on no more than two public company boards including Synopsys; other independent directors may serve on up to four. Compliance for nominees is assessed annually; policy statement provided for context .
Expertise & Qualifications
- Enterprise software and simulation leadership (Ansys CEO/COO; systems engineering and multiphysics simulation integration) .
- Private equity operating experience (Silver Lake), enterprise software operations (HPE), and interim transformation leadership (Symantec) .
- Public company board experience across technology sectors (Fiserv, Citrix) .
Equity Ownership
| As‑Of Date | Instrument | Quantity/Detail | Post‑Txn Holdings | Source |
|---|---|---|---|---|
| July 17, 2025 (Form 3 event) | Common Stock | 95,503 shares (direct) | 95,503 | |
| July 17, 2025 (Form 3) | RSUs (time‑based; converted from Ansys) | 36,856; 6,009; 27,795; 46,596 (various schedules) | N/A | |
| July 31, 2025 (Form 4) | RSU vesting and share withholding for taxes | 117,256 RSUs vested; 46,153 shares withheld at $633.47 for taxes; no open‑market sales | Direct holdings increased to 166,606 shares |
Policy notes: Synopsys prohibits director hedging and pledging of company stock; non‑employee directors are expected to reach stock ownership equal to 3x annual cash retainer or 15,000 shares within 3 years of initial election and maintain it thereafter (guidelines updated December 2023) .
Governance Assessment
Strengths
- Strategic fit and integration expertise: Direct leadership of Ansys positions Gopal to enhance board oversight of silicon‑to‑systems integration post‑merger; appointment was contemplated by the merger agreement to support integration .
- Clean conflicts profile at appointment: No family relationships; no Item 404(a) related‑party transactions; standard indemnification; participation in non‑employee director program indicates independence of role .
- Alignment mechanisms: Time‑based director RSUs and stock ownership guidelines; hedging/pledging prohibitions; strong overall board governance practices (majority voting, independent committees) .
Watch items
- Committee influence: No committee assignment at appointment; investors may watch for eventual placement (Audit/Governance/Compensation) to leverage operating expertise .
- Overboarding monitoring: Synopsys policy limits executives of public companies to two public boards including Synopsys; Gopal also serves on Fiserv’s board. Continued compliance should be monitored alongside any future executive or board roles; policy framework provided for context .
- Equity transitions: July 2025 RSU conversions/accelerations were M&A‑driven; Form 4 indicates tax withholding only with no open‑market sales, supportive of alignment and not a liquidity‑driven disposition .
Shareholder sentiment context
- 2025 annual say‑on‑pay: For 113,853,659; Against 11,142,380; Abstain 1,171,317; broker non‑votes 12,427,073 (advisory approval) .
- Governance engagements: Synopsys reports ongoing investor outreach and strong board refreshment processes, including lead independent director transition and committee compositions; context for investor confidence but not specific to Gopal .
Insider Trades (selected)
| Date | Filing | Transaction | Shares | Price | Resulting Holdings | Notes |
|---|---|---|---|---|---|---|
| 2025‑07‑24 | Form 3 | Initial beneficial ownership on joining board | 95,503 common; RSUs: 36,856; 6,009; 27,795; 46,596 | N/A | 95,503 common | Converted Ansys awards to Synopsys RSUs per merger terms |
| 2025‑07‑31 | Form 4 | RSU vesting; tax withholding only | 117,256 vested; 46,153 withheld | $633.47 (withholding reference) | 166,606 common | No open‑market sales reported |
Related‑Party / Conflicts Review
- At appointment, Synopsys disclosed no material related‑party transactions for Gopal, and no family relationships with directors/executives. He will receive standard non‑employee director compensation and standard indemnification .
- Company‑wide, the Audit Committee oversees and pre‑approves related‑party transactions under a formal policy; none over $120,000 were reported from the beginning of FY2024 through the proxy’s publication, other than routine compensation .
Director Compensation Structure (context and 2024 levels)
| Component | FY2024 Amount | Notes |
|---|---|---|
| Cash: Board retainer | $125,000 | Paid quarterly in advance |
| Cash: Lead Independent Director | +$30,000 | Role‑based |
| Cash: Committee Chairs | Audit +$40,000; Comp +$25,000; Gov +$25,000 | Role‑based |
| Cash: Committee Members | Audit +$15,000; Comp +$10,000; Gov +$10,000 | Role‑based |
| Equity: Annual award | ~$200,000 restricted stock | Time‑based vesting before next annual meeting; FY2024 example 356 shares at $561.23 |
Note: For FY2025, Synopsys made no changes to non‑employee director compensation levels vs. FY2024 . Gopal’s initial/interim RSU grants follow the 2025 8‑K terms shown above .
Equity Ownership & Alignment Policies
- Non‑employee director ownership guideline: the lesser of 3x annual cash retainer or 15,000 shares, to be achieved within 3 years of initial election and maintained thereafter; directors are encouraged to retain a portion of vested shares to meet/maintain guidelines .
- Hedging/Pledging: Policies prohibit hedging and pledging by directors .
Notes on Committee Landscape (pre‑Ansys close)
- As of the April 10, 2025 annual meeting: Audit (Chair: Mercedes Johnson); Compensation (Chair: John G. Schwarz; Chair to transition to Robert G. Painter after the meeting); Governance (Chair: Janice D. Chaffin). These rosters did not yet include Gopal (appointed in July 2025) .
Citations
- Appointment, compensation on joining, lack of related‑party interests, and background:
- Indemnification agreement:
- 2025 proxy governance, committee structures, director compensation framework, stock ownership guidelines, related‑party policy, board attendance context:
- Annual meeting vote results (2025):
- Form 3 (initial beneficial ownership upon joining Synopsys board):
- Form 4 (RSU vesting/tax withholding):